Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta cir. bras ; 29(11): 735-741, 11/2014. tab, graf
Artigo em Inglês | LILACS | ID: lil-728650

RESUMO

PURPOSE: To evaluate intestinal inflammatory and apoptotic processes after intestinal ischemia/reperfusion injury, modulated by pentoxifylline and hypertonic saline. METHODS: It was allocated into four groups (n=6), 24 male Wistar rats (200 to 250g) and submitted to intestinal ischemia for 40 min and reperfusion for 80 min: IR (did not receive any treatment); HS group (Hypertonic Saline, 4ml/kg-IV); PTX group (Pentoxifylline, 30mg/kg-IV); HS+PTX group (Hypertonic Saline and Pentoxifylline). All animals were heparinized (100U/kg). At the end of reperfusion, ileal fragments were removed and stained on hematoxylin-eosin and histochemical studies for COX-2, Bcl-2 and cleaved caspase-3. RESULTS: The values of sO2 were higher on treated groups at 40 minutes of reperfusion (p=0.0081) and 80 minutes of reperfusion (p=0.0072). Serum lactate values were lower on treated groups after 40 minutes of reperfusion (p=0.0003) and 80 minutes of reperfusion (p=0.0098). Morphologic tissue injuries showed higher grades on IR group versus other groups: HS (p=0.0006), PTX (p=0.0433) and HS+PTX (p=0.0040). The histochemical study showed lesser expression of COX-2 (p=0.0015) and Bcl-2 (p=0.0012) on HS+PTX group. A lower expression of cleaved caspase-3 was demonstrated in PTX (p=0.0090; PTXvsIR). CONCLUSION: The combined use of pentoxifylline and hypertonic saline offers best results on inflammatory and apoptotic inhibitory aspects after intestinal ischemia/reperfusion. .


Assuntos
Animais , Masculino , Apoptose/efeitos dos fármacos , Intestinos/irrigação sanguínea , Isquemia/complicações , Pentoxifilina/farmacologia , Inibidores de Fosfodiesterase/farmacologia , Traumatismo por Reperfusão/prevenção & controle , Solução Salina Hipertônica/farmacologia , /análise , /análise , Imuno-Histoquímica , Intestinos/efeitos dos fármacos , Isquemia/prevenção & controle , Ácido Láctico/sangue , Oxigênio/metabolismo , Pentoxifilina/uso terapêutico , Inibidores de Fosfodiesterase/uso terapêutico , Ratos Wistar , Valores de Referência , Reprodutibilidade dos Testes , Traumatismo por Reperfusão/sangue , Solução Salina Hipertônica/uso terapêutico , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA